Medical Daily | European Agency Favors Remicade Biosimilars MedPage Today Other biosimilars are available in Europe, such as Nivestim, which is similar to the granulocyte colony-stimulating factor analog filgrastim, and product-specific guidelines for monoclonal antibodies have been established by the medicines agency ... 'Biosimilar' drug ruling to hit Big Pharma EMA's CHMP backs approval of first two monoclonal antibody biosimilars of ... A Pivotal Decision By European Drug Regulators on Remicade Is Unlikely To ... |
